Heinz-Georg Wetzstein

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Animal Health Gmbh. Active years: 1996-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz-Georg Wetzstein. Retrieved from https://idiyas.com/inventor/heinz-georg-wetzstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 42(Granted Patents)

Location History:

Koln, DE (1998)
Leverkusen, DE (1996 - 2019)

Company Filing History:

10 out of 12,268

Bayer Aktiengesellschaft

patents

1 out of 54

Bayer Animal Health Gmbh

patents

Years Active: 1996-2019

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10265330 - Pharmaceutical compositions and treatment of mastitis (2019-04-23),

2. 6323213 - Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives (2001-11-27),

3. 6278013 - Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives (2001-08-21),

4. 6046045 - Methods for decomposing quinolones and naphthyridones (2000-04-04),

5. 5854241 - Pyrido�3,2,1-I,J!�3,1!benzoxazine derivatives (1998-12-29),

6. 5744478 - Thiazolo �3,2-a! quinoline and thiazolo �3,2-a! naphthyridine derivatives (1998-04-28),

7. 5679675 - 8-amino-10-(azabicycloalkyl)-pyrido�1,2,3-d,e!�1,3,4!benzoxadiazine (1997-10-21),

8. 5659038 - 5-vinyl-and 5-ethinyl-quinolone- and -naphthyridone-carboxylic acids (1997-08-19),

9. 5618815 - 1,9-bridged thiazolo[3,2-a]quinoline derivatives (1997-04-08),

10. 5578604 - 5-vinyl- and 5-ethinyl-quinolone- carboxylic acids (1996-11-26),

11. 5508278 - Pyrido[1,2,3-D,E] [1,3,4]benzoxadiazine derivatives (1996-04-16),

Title: The Innovations of Heinz-Georg Wetzstein

Introduction

Heinz-Georg Wetzstein is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mastitis in non-human mammals. With a total of 11 patents to his name, Wetzstein's work has had a considerable impact on veterinary medicine.

Latest Patents

Wetzstein's latest patents include innovative pharmaceutical compositions aimed at treating and preventing mastitis in cows. One of his notable inventions involves a pharmaceutical composition that combines a phosphonic acid with at least one antimicrobial agent. This invention addresses the critical issue of mastitis, which affects the health and productivity of dairy cows. Another significant patent features novel optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives, showcasing his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Wetzstein has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Animal Health GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of veterinary pharmaceuticals.

Collaborations

Wetzstein has collaborated with esteemed colleagues, including Michael Stegemann and Thomas Jaetsch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of animal health.

Conclusion

Heinz-Georg Wetzstein's contributions to veterinary medicine through his innovative patents demonstrate his dedication to improving animal health. His work continues to influence the industry and provides valuable solutions for the treatment of mastitis in livestock.

Profile summary based on public USPTO records.